Literature DB >> 7926596

The effect of deferoxamine on brain lipid peroxide levels and Na-K ATPase activity following experimental subarachnoid hemorrhage.

A Bilgihan1, N Türközkan, A Aricioğlu, S Aykol, C Cevik, M Göksel.   

Abstract

1. In the present study we have studied the effects of deferoxamine treatment on lipid peroxidation and Na-K ATPase activity after experimental induction of subarachnoid haemorrhage (SAH) in guinea pigs. 2. We assessed the extent of lipid peroxidation by measuring the level of malondialdehyde and Na-K ATPase activity in 3 different groups (sham-operated, SAH, SAH + deferoxamine). 3. There was no significant difference in lipid peroxide content between sham-operated and haemorrhagic animals, but Na-K ATPase activity decreased after SAH. 4. Deferoxamine treatment reduced the malondialdehyde content and induced the recovery of Na-K ATPase activity, exerting a brain protective role against the detrimental effects of the haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926596     DOI: 10.1016/0306-3623(94)90204-6

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

Review 1.  Antioxidant strategies in neurocritical care.

Authors:  Khalid A Hanafy; Magdy H Selim
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?

Authors:  Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-14       Impact factor: 6.200

3.  Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.

Authors:  R E Ayer; J H Zhang
Journal:  Acta Neurochir Suppl       Date:  2008

Review 4.  Antioxidants: The new frontier for translational research in cerebroprotection.

Authors:  Anurag Tewari; Vidhi Mahendru; Ashish Sinha; Federico Bilotta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-04

5.  Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine.

Authors:  Robert H LeBlanc; Ruiya Chen; Magdy H Selim; Khalid A Hanafy
Journal:  J Neuroinflammation       Date:  2016-09-13       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.